Reckitt Benckiser said strong growth from recently-acquired brands Nurofen and Strepsils helped it deliver a 15% rise in full-year profits today.

UK household goods firm Reckitt Benckiser is expanding its healthcare operations in North America after today agreeing a £1.1bn (€1.5bn) takeover of a US cough mixture firm.

British retailer Boots has lined up a shortlist of six in the £1.2bn auction of its Nurofen-to-Clearasil business, it was reported today.